Cargando…
Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm
SIMPLE SUMMARY: Mutation and protein-level profiling has expanded our understanding of the pathogenesis of blastic plasmacytoid dendritic cell neoplasm (BPDCN) and offered insights into potential therapeutic vulnerabilities. However, the prognostic impact of gene mutations in this disease remains co...
Autores principales: | Yin, C. Cameron, Pemmaraju, Naveen, You, M. James, Li, Shaoying, Xu, Jie, Wang, Wei, Tang, Zhenya, Alswailmi, Omar, Bhalla, Kapil N., Qazilbash, Muzaffar H., Konopleva, Marina, Khoury, Joseph D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656770/ https://www.ncbi.nlm.nih.gov/pubmed/34884997 http://dx.doi.org/10.3390/cancers13235888 |
Ejemplares similares
-
Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm
por: Economides, Minas P., et al.
Publicado: (2019) -
TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm
por: Beird, Hannah, et al.
Publicado: (2023) -
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD
por: Pemmaraju, Naveen, et al.
Publicado: (2022) -
Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm
por: Wang, Wei, et al.
Publicado: (2022) -
PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm
por: Aung, Phyu P., et al.
Publicado: (2019)